PHASIFY™ is a novel sample preparation technology based on a proprietary liquid phase extraction mechanism. The technique achieves significantly greater yield of circulating cell-free DNA (cfDNA) compared to traditional solid phase methods such as spin columns and magnetic beads. Further, the PHASIFY™ platform provides modifiable, high-resolution size selection to enrich for target sizes of cfDNA.

In a head-to-head study at MD Anderson Cancer Center, PHASIFY™ demonstrated threefold greater cfDNA yield against traditional solid phase extraction, resulting in increased mutation detection in cancer patient plasma samples.

PHASIFY™ Advantage

High Yield: Multiple fold increase in cell-free DNA recovery compared to solid phase extraction, resulting in increased mutation detection and sensitivity
Size Selection: Modifiable and high-resolution size selection to enrich for target cfDNA (e.g., tumor DNA for oncology or circulating fetal DNA for NIPT)
High Concentration: Flexible elution volume as low as 5 µL, enabling high final DNA concentration and maximizing DNA input for downstream diagnostics
Scalability: High sample input volumes without clogging and loss in throughput

Product

PHASIFY™ MAX

High Yield cfDNA Extraction Kit

PHASIFY™ ENRICH

High Yield cfDNA Extraction Kit with
Size Selection

Products are for Research Use Only